Moderna expects COVID-19 vaccine trial results by November, CEO says

Biotech firm Moderna expects to know by November whether its coronavirus vaccine is effective at warding off the deadly disease, CEO Stephane Bancel said Thursday. Massachusetts-based Moderna says it has enrolled 25,296 people in the late-stage clinical trial of its COVID-19 vaccine that kicked off in July, one of three such studies currently underway in… Continue reading at New York Post